Publications by authors named "Maria Gabriella Guidetti"
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab.
Savino Sciascia Maria Letizia Antonietta Rilat Roberta Fenoglio Silvia Grazietta Foddai Massimo Radin Maria Gabriella Guidetti
Clin Kidney J
September 2023
Article Synopsis
- * After administering the treatment to 22 patients, none developed symptomatic SARS-CoV-2 infections during the observation period, while 39.3% of the control group experienced symptomatic infections, highlighting the treatment's potential benefits.
- * Overall, the findings suggest that tixagevimab/cilgavimab is a safe option that may significantly reduce the risk of symptomatic COVID-19 infections for vaccinated individuals with GD on anti-CD20 therapy.